Drawing for ARASTATIN

USPTO serial 79448312

ARASTATIN

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
TWOHIG, SHANNON MARIE
Law office
TMEG LAW OFFICE 105

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with ARASTATIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Catherine F. Hoffman

Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell & Berkowitz, PC200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science; bioactive reagents and compounds; peptides, peptide derivatives, proteins, glycans, nucleotides, lipids, antibodies, antibody-active principle conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; chemical, biochemical, biological, biotechnological and molecular genetic preparations for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides, peptide derivatives or proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.ACTIVE—
005Pharmaceutical products, medical preparations; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely peptides, peptide derivatives, proteins, antibodies, active antibody conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; pharmaceutical products and substances for the treatment of diseases and preparations for medical treatments.ACTIVE—
035Providing information with respect to business contacts for research projects.ACTIVE—
042Scientific and technological services as well as research work and design services relating thereto, namely, services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; services of a biochemical or pharmaceutical laboratory; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Jul 28, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 28, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 25, 2026RFNTREFUSAL PROCESSED BY IB—
Jun 11, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 11, 2026RFRRREFUSAL PROCESSED BY MPU—
Apr 28, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2026DOCKASSIGNED TO EXAMINER—
Apr 22, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 22, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance